1-Hydroxybenzotriazole → 2-hydroxy-8-phenyl-N-((5-phenyl-1,3,4-oxadiazol-2-yl)methyl)octanamide
反応式
[OH:1][CH:2]([CH2:6][CH2:7][CH2:8][CH2:9][CH2:10][CH2:11][C:12]1[CH:17]=[CH:16][CH:15]=[CH:14][CH:13]=1)[C:3]([OH:5])=O.C(O)(=O)C(O)=O.[C:24]1([C:30]2[O:34][C:33]([CH2:35][NH2:36])=[N:32][N:31]=2)[CH:29]=[CH:28][CH:27]=[CH:26][CH:25]=1.C1C=CC2N(O)N=NC=2C=1.C(N(C(C)C)CC)(C)C.Cl.C(N=C=NCCCN(C)C)C>CN(C=O)C>[OH:1][CH:2]([CH2:6][CH2:7][CH2:8][CH2:9][CH2:10][CH2:11][C:12]1[CH:17]=[CH:16][CH:15]=[CH:14][CH:13]=1)[C:3]([NH:36][CH2:35][C:33]1[O:34][C:30]([C:24]2[CH:25]=[CH:26][CH:27]=[CH:28][CH:29]=2)=[N:31][N:32]=1)=[O:5]参加物
7
反応物 5
生成物 1
試薬・触媒・溶媒 1
実験手順
To a solution of 2-hydroxy-8-phenyloctanoic acid (458 mg, 1.94 mmol), 5-phenyl-1,3,4-oxadiazol-2-yl methanamine oxalate (514 mg, 1.94 mmol), HOBt (314 mg, 2.3 mmol) and diisopropylethyl amine (501 mg, 3.9 mmol) in DMF (15 mL) was added 1-ethyl-3(3-dimethylaminopropyl) carbodiimide hydrochloride (446 mg, 2.3 mmol). The suspension was stirred for 48 h then filtered. The filtrate was diluted with EtOAc and washed sequentially with water, saturated NaHCO3, and brine. The organic phase was dried (Na2SO4) and filtered and the residue triturated with EtOAc to yield 2-hydroxy-8-phenyl-N-((5-phenyl-1,3,4-oxadiazol-2-yl)methyl)octanamide (MH+=394).
後処理
- filtrationthen filtered
- additionThe filtrate was diluted with EtOAc
- washwashed sequentially with water, saturated NaHCO3, and brine
- dry with materialThe organic phase was dried (Na2SO4)
- filtrationfiltered
- customthe residue triturated with EtOAc
出典と根拠
- ORDレコード
- ord-58726b9c410d457bb9ef4c7b17f6a3c0
- 出典データセット
- uspto-grants-2013_07
- 特許番号
- US08476302B2
反応ノート
読み込み中…